Pharma-Bio Serv (PBSV) Earnings Date, Estimates & Call Transcripts → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free PBSV Stock Alerts $0.70 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share EarningsStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest Earnings SummaryUpcoming Earnings DateJun. 12EstimatedActual EPS (Mar. 18) -$0.01 Missed By -$0.03 Consensus EPS (Mar. 18) $0.02 Get Pharma-Bio Serv Earnings AlertsEnter your email address below to receive the latest news and earnings results for PBSV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePBSV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PBSV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Pharma-Bio Serv Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.02$0.02$0.02Q2 20241$0.03$0.03$0.03Q3 20241$0.03$0.03$0.03Q4 20241$0.03$0.03$0.03FY 20244$0.11$0.11$0.11Q1 20251$0.02$0.02$0.02Q2 20251$0.03$0.03$0.03Q3 20251$0.03$0.03$0.03Q4 20251$0.03$0.03$0.03FY 20254$0.11$0.11$0.11PBSV Earnings Date and InformationPharma-Bio Serv last issued its earnings data on March 18th, 2024. The reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The business earned $2.38 million during the quarter, compared to the consensus estimate of $5 million. Pharma-Bio Serv has generated $0.03 earnings per share over the last year ($0.03 diluted earnings per share) and currently has a price-to-earnings ratio of 23.3. Earnings for Pharma-Bio Serv are expected to grow by 37.50% in the coming year, from $0.08 to $0.11 per share. Pharma-Bio Serv has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 12th, 2024 based off prior year's report dates.Read More Pharma-Bio Serv Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/12/2024Estimated)------- 3/18/2024Q1 2024$0.02($0.01)($0.03)($0.01)$5.00 million$2.38 million1/29/2024Q4 2023$0.03$0.03--$5.00 million$3.60 million9/14/2023Q3 2023$0.02$0.02-$0.02$5.40 million$4.58 million6/14/2023Q2 2023$0.02$0.02-$0.02$5.00 million$4.56 million3/17/2023Q1 2023$0.01$0.02+$0.01$0.02$5.00 million$4.24 million1/30/2023Q4 2022-$0.01+$0.01$0.01-$4.64 million Get the Latest News and Ratings for PBSV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter. 9/14/2022Q3 2022-$0.01+$0.01$0.01-$4.77 million6/14/2022Q2 2022-$0.01+$0.01$0.01-$4.97 million3/17/2022Q1 2022-$0.01+$0.01$0.01-$5.02 million2/11/2022Q4 2021-($0.21)($0.21)($0.21)-$5.60 million9/14/2021Q3 2021-$0.10+$0.10$0.10-$4.99 million6/14/2021Q2 2021-$0.01+$0.01$0.01-$5.04 million Pharma-Bio Serv Earnings - Frequently Asked Questions When is Pharma-Bio Serv's earnings date? Pharma-Bio Serv has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 12th, 2024 based off last year's report dates. Learn more on PBSV's earnings history. Did Pharma-Bio Serv beat their earnings estimates last quarter? In the previous quarter, Pharma-Bio Serv (OTCMKTS:PBSV) missed the analysts' consensus estimate of $0.02 by $0.03 with a reported earnings per share (EPS) of ($0.01). Learn more on analysts' earnings estimate vs. PBSV's actual earnings. How much revenue does Pharma-Bio Serv generate each year? Pharma-Bio Serv (OTCMKTS:PBSV) has a recorded annual revenue of $16.98 million. How much profit does Pharma-Bio Serv generate each year? Pharma-Bio Serv (OTCMKTS:PBSV) has a recorded net income of $1.31 million. PBSV has generated $0.03 earnings per share over the last four quarters. What is Pharma-Bio Serv's price-to-earnings ratio? Pharma-Bio Serv (OTCMKTS:PBSV) has a trailing price-to-earnings ratio of 23.34 and a forward price-to-earnings ratio of 8.75. What is Pharma-Bio Serv's EPS forecast for next year? Pharma-Bio Serv's earnings are expected to grow from $0.08 per share to $0.11 per share in the next year, which is a 37.50% increase. More Earnings Resources from MarketBeat Related Companies: Castellum Earnings ATIF Earnings Aeries Technology Earnings The Glimpse Group Earnings Professional Diversity Network Earnings Vivakor Earnings The Arena Group Earnings Urgent.ly Earnings Dalrada Financial Earnings Getaround Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (OTCMKTS:PBSV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.